Clinical Symptoms and Treatment of Systemic Red Lupus

Clinical Symptoms and Treatment of Systemic Red Lupus

Systemic erythalamus (SLE) is a serious self-immunological disease that can weigh on multiple systems and organs of the whole body.

The clinical symptoms are diverse and complex. SLE is often the first expression of skin symptoms, the most characteristic of which is a butterfly-shaped red spot with a line across the nostrils and double cheeks like butterflies, which are clear and symmetrically distributed. Carbide-shaped red spots are also more common, most of which are red spots with clear borders, in circular or elliptical shapes, so that they can be found in exposed parts of the head, neck, etc. In addition, there may be mucous membranes, ulcer etc. in the skin.

In the case of joint muscles, most patients suffer from arthritis pain, which can be drawn to multiple joints, such as fingers, wrists, knees, etc., while some patients may also experience morning rigidity but generally do not cause joint malformations. Muscle stress can be manifested in muscle incompetence, pain and reduced activity endurance, which seriously affects patients ‘ daily activities.

The patient ‘ s immune system wrongfully attacks his or her tissues and organs, and can be drawn to multiple parts of the skin, joints, kidneys, blood system, etc. On the skin, there may be typical butterfly-shaped red spots, cross-nose beams and cheeks on both sides of the cheeks, and there may be manifestations such as plate-shaped red spots. Artificial pain, swelling is common and can be drawn to multiple joints.

Renal stress may be manifested in protein urine, blood urine, etc., and serious kidney disease can affect kidney function. With regard to the blood system, there is a decrease in white cells, a decrease in platelets, anaemia, etc.

The kidneys are one of SLE’s most common organs. Kidney disease can be manifested in protein urine, blood urine, edema, etc., and severe kidney damage can develop into kidney failure, which greatly affects the patient ‘ s prognosis and quality of life.

The blood system is also frequently violated, with a decrease in white cells, a decrease in blood platelets and anemia. The reduction in white cells reduces the resistance of patients and their vulnerability to infection; the reduction of the slab can lead to skin bruises, bruises, nose, tooth bleeding, etc.; and anaemia can cause discomfort in the face, dizziness, lack of strength, etc.

Cardiac encephalitis, myocarditis, etc. can be found in the heart, in the form of chest pain, heart attack, respiratory difficulties, etc. Pulmonary stress can lead to pleuralitis, inter-pulmonary pathologies and symptoms of chest pain, cough and respiratory difficulties.

For SLE treatments, sugar cortex hormones is the primary drug, which quickly controls inflammation and reduces symptoms. Depending on the severity of the condition, a gradual reduction after abating from the condition is used at different doses. Immunosuppressants also play a key role in treatment, such as cyclophosphate, cocophenate, which inhibits immune response, reduces relapse, and protects critical body function, especially for patients with major body damage such as kidneys. For some incurable or serious cases, biological agents can also be used for target treatment. At the same time, care is taken to avoid suntanning, the use of UV-resistant supplies, routines, the prevention of infection and the maintenance of a good mental state, active cooperation with treatment and periodic review so that doctors can adjust their treatment programmes in a timely manner.